Taiwan FDA registration 670170a433c3a65761a4ff7f8170874f
DirectCHECK Whole Blood Control
TW: 德確 全血品管液
Taiwan·Risk Class 2·MD·Accriva Diagnostics Inc.·Registered Oct 24, 2017 – Oct 24, 2027ActiveRegistration details
- Analysis ID
- 670170a433c3a65761a4ff7f8170874f
- License Form
- Ministry of Health Medical Device Import No. 030087
- Customs Code
- DHA05603008709
Company information
- Manufacturer
- Accriva Diagnostics Inc.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- Quality control materials for monitoring Hammock microcoagulation time analyzers.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 24, 2017
- Expiry Date
- Oct 24, 2027
About this record
Access comprehensive regulatory information for DirectCHECK Whole Blood Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 670170a433c3a65761a4ff7f8170874f and manufactured by Accriva Diagnostics Inc.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices